|
|||||
|
Latest Insider Trading | Top Insider Trading Recent Week | Top 10% Owner Trading Recent Week | Filter |
Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Form 4 |
---|---|---|---|---|---|---|---|---|---|
BCRX | Sheridan William P | Chief Medical Officer | Mar 10 | Option Exercise | 3.22 | 148,302 | 477,532 | 199,093 | Mar 14 04:21 PM |
BCRX | Sheridan William P | Chief Medical Officer | Mar 10 | Sale | 16.88 | 161,139 | 2,719,493 | 37,954 | Mar 14 04:21 PM |
BCRX | Sheridan William P | Chief Medical Officer | May 27 | Option Exercise | 5.27 | 71,759 | 378,114 | 86,234 | Jun 01 04:33 PM |
BCRX | Sheridan William P | Chief Medical Officer | May 28 | Option Exercise | 5.38 | 91,814 | 493,826 | 106,289 | Jun 01 04:33 PM |
BCRX | Sheridan William P | Chief Medical Officer | May 28 | Sale | 15.02 | 91,814 | 1,379,046 | 14,475 | Jun 01 04:33 PM |
BCRX | Sheridan William P | Chief Medical Officer | May 27 | Sale | 15.00 | 71,759 | 1,076,385 | 14,475 | Jun 01 04:33 PM |
BCRX | Sheridan William P | Senior VP - CMO | Feb 22 | Option Exercise | 4.15 | 41,250 | 171,188 | 52,725 | Feb 24 04:34 PM |
BCRX | Sheridan William P | Senior VP - CMO | Feb 22 | Sale | 11.57 | 41,250 | 477,262 | 11,475 | Feb 24 04:34 PM |
BCRX | Sheridan William P | Senior VP - CMO | Dec 18 | Sale | 7.58 | 20,488 | 155,299 | 2,725 | Dec 20 04:37 PM |
BCRX | Sheridan William P | Senior VP - CMO | Aug 09 | Option Exercise | 1.42 | 62,500 | 88,750 | 85,713 | Aug 13 10:07 AM |
BCRX | Sheridan William P | Senior VP - CMO | Aug 09 | Sale | 7.03 | 62,500 | 439,375 | 23,213 | Aug 13 10:07 AM |
BCRX | Sheridan William P | Senior VP - CMO | Jun 01 | Option Exercise | 2.58 | 42,112 | 108,649 | 63,170 | Jun 05 03:07 PM |
BCRX | Sheridan William P | Senior VP - CMO | Jun 01 | Sale | 6.30 | 42,112 | 265,306 | 21,058 | Jun 05 03:07 PM |
BCRX | Sheridan William P | Senior VP - CMO | Nov 13 | Sale | 4.72 | 64,310 | 303,543 | 23,855 | Nov 15 04:09 PM |
BCRX | Sheridan William P | Senior VP - CMO | Jun 19 | Option Exercise | 1.20 | 70,389 | 84,467 | 165,512 | Jun 22 04:48 PM |
BCRX | Sheridan William P | Senior VP - CMO | Jun 19 | Sale | 15.05 | 70,389 | 1,059,354 | 95,123 | Jun 22 04:48 PM |
BCRX | Sheridan William P | Senior VP - CMO | Dec 30 | Option Exercise | 1.42 | 23,104 | 32,808 | 115,622 | Dec 31 02:11 PM |
BCRX | Sheridan William P | Senior VP - CMO | Dec 29 | Option Exercise | 4.25 | 48,396 | 205,742 | 197,813 | Dec 31 02:11 PM |
BCRX | Sheridan William P | Senior VP - CMO | Dec 29 | Sale | 12.43 | 105,295 | 1,308,817 | 92,518 | Dec 31 02:11 PM |
BCRX | Sheridan William P | Senior VP - CMO | Dec 30 | Sale | 12.06 | 23,104 | 278,634 | 92,518 | Dec 31 02:11 PM |
BCRX | Sheridan William P | Senior VP - CMO | Jun 03 | Option Exercise | 4.73 | 21,228 | 100,333 | 150,872 | Jun 05 02:15 PM |
BCRX | Sheridan William P | SR VP - CMO | May 28 | Option Exercise | 1.20 | 16,407 | 19,688 | 82,274 | May 29 04:00 PM |
BCRX | Sheridan William P | SR VP - CMO | Mar 02 | Sale | 4.78 | 956 | 4,570 | 29,330 | Mar 05 03:38 PM |
BCRX | Sheridan William P | SR VP - CMO | Apr 08 | Option Exercise | 2.13 | 18,593 | 39,562 | 20,257 | Apr 12 02:05 PM |
BCRX | Sheridan William P | SR VP - CMO | Apr 08 | Sale | 8.01 | 18,593 | 148,856 | 1,664 | Apr 12 02:05 PM |
BCRX | Sheridan William P | SR VP - CMO | Jan 11 | Option Exercise | 2.58 | 4,166 | 10,748 | 4,166 | Jan 12 05:49 PM |
BCRX | Sheridan William P | SR VP - CMO | Jan 11 | Sale | 8.05 | 4,166 | 33,536 | 0 | Jan 12 05:49 PM |
BCRX | Sheridan William P | SR VP - CMO | Dec 01 | Option Exercise | 2.58 | 4,167 | 10,751 | 4,167 | Dec 02 06:35 PM |
BCRX | Sheridan William P | SR VP - CMO | Dec 01 | Sale | 8.17 | 4,167 | 34,044 | 0 | Dec 02 06:35 PM |
BCRX | Sheridan William P | SR VP - CMO | Oct 14 | Sale | 8.92 | 6,000 | 53,540 | 0 | Oct 15 02:50 PM |
BCRX | Sheridan William P | SR VP - CMO | Jan 30 | Buy | 1.61 | 3,000 | 4,845 | 3,000 | Feb 03 11:02 AM |
Join thousands of traders who make more informed decisions with our premium features. Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite